MAFIxekizumab (Taltz) Prefilled Pen 80 mg/mL
Additional clinical criteria applies
1) Treatment of adult patients with ankylosing spondylitis
2) Treatment of adult patients with psoriatic arthritis with axial involvement
3) Treatment of adult patients with psoriatic arthritis with peripheral involvement
4) Treatment of adult patients with chronic plaque psoriasis